Eaton Vance Tax-Advantage Global Dividend Opp (ETO) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed Eaton Vance Tax-Advantage Global Dividend Opp (ETO) over the past year, gaining 11.2% versus a gain of 8.8%. Over five years, ETO leads with a -4.5% price change compared with -15.0% for HQL. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 3.6x for Eaton Vance Tax-Advantage Global Dividend Opp).
abrdn Life Sciences Investors offers the higher dividend yield (10.88% vs 6.84%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETO | HQL |
|---|---|---|
| Share price | $30.39 | $17.56 |
| Market cap | $498.04M | — |
| 1-day change | -0.49% | 0.00% |
| YTD return | +0.13% | +4.65% |
| 1-year return | +8.85% | +11.21% |
| 5-year return | -4.52% | -15.00% |
| P/E ratio (TTM) | 3.65 | 2.64 |
| EPS (TTM) | $8.33 | $6.64 |
| Dividend yield | 6.84% | 10.88% |
| Annual dividend | $2.08 | $1.91 |
| 52-week high | $32.35 | $22.67 |
| 52-week low | $25.68 | $15.66 |
| Distance from 52-week high | -6.06% | -22.54% |
| Analyst consensus | strong_buy | — |
| Average volume | 23.66K | 147.31K |
| Shares outstanding | 16.39M | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eaton Vance Tax-Advantage Global Dividend Opp trades at a higher earnings multiple (3.6x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.88% vs 6.84%).
About Eaton Vance Tax-Advantage Global Dividend Opp
ETO stock →Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe.
Finance · Investment Managers
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
ETO vs HQL FAQ
Which stock has performed better over the past year, ETO or HQL?
HQL returned +11.21% over the past 12 months, compared with +8.85% for ETO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ETO or HQL?
HQL has the lower trailing P/E at 2.6, versus 3.6 for ETO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Eaton Vance Tax-Advantage Global Dividend Opp or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 10.88%, compared with 6.84% for Eaton Vance Tax-Advantage Global Dividend Opp.
Are Eaton Vance Tax-Advantage Global Dividend Opp and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.